Latest filing published 29 Jul 2025 for CalciMedica, Inc., €3,105. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Kenneth A. Stauderman in CalciMedica, Inc. Between 20 March 2023 and 25 July 2025, the trades on record add up to 3 filings.
Both buying and selling appear: 1 purchase worth €1,567, against 1 sale worth €3,105. Sales outweigh purchases by €1,538. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. So far in 2025, the count stands at 1 purchase and 1 sale.
The newest entry dates from 29 July 2025: an open-market sale of €3,105, in CalciMedica, Inc. The clock since the last published purchase (2 July 2025) now reads 473 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations